P2D, Inc.   Report issue

For profit Phase 1
Founded: Cincinnati OH United States (2004)
Status: Left NME R&D (2019)

Organization Overview

First Clinical Trial
2009
NCT00829881
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now